Cidofovir (Vistide) injection 375mg/5ml single dose vial NDC 23155-216-31

This is a Small Business Sources Sought Notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding: (1) the availability and capability of qualified small business sources; (2) whether they are small businesses; HUBZone small business; woman-owned small business; or small disadvantaged business; and (3) their size classification relative to the North American Industry Classification System (NAICS) code for the proposed acquisition. Your responses to the information requested will assist the Government in determining the appropriate acquisition method, including whether a set-aside is possible. An organization that is not considered a small business under the applicable NAICS code should not submit a response to this notice.
The purpose of this acquisition is to acquire and deliver Cidofovir 375mg/5ml injection single dose vials to the DSNS in accordance with the delivery schedule outlined below.

For further information, please see the attachment.

All capability statements sent in response to this Sources Sought Notice must be submitted to Heather Orandi, Contract Specialist, via email at Heather.Orandi@hhs.gov before the closing date and time of this announcement. All responses must be received by the specified due date and time in order to be considered.

.